RU version is available. Content is displayed in original English for accuracy.
Advertisement
Advertisement
⚡ Community Insights
Discussion Sentiment
75% Positive
Analyzed from 773 words in the discussion.
Trending Topics
#atlassian#data#anthropic#jira#claude#tickets#better#last#years#maybe

Discussion (19 Comments)Read Original on HackerNews
Initially I wanted to write this comment saying buying them would be a bad idea just for the technical debt... But maybe they have the perfect "already vibe coded by humans" software to have an AI company take over.
Atlassian's is $19 billion.
Is Anthropic really worth 40x Atlassian? If so, is it worth them spending just 2.5% of their valuation to acquire Atlassian's 300,000 enterprise customers?
I would be very bullish if this were to happen.
I'm usually the last one to suggest that you can vibe code a SaaS clone, but this is an exception.
JIRA clone is generic enough that it might even be a good agent benchmark.
1. Data, forget Jira tickets, but Confluence and Service Desk could be valuable for requirements shaping on the model. 2. Customers, as it's easy NRR to include on their balance sheet and would help with an IPO. 3. Infra, Atlassian has been remarkably stable for the last few years (in my region at least) while Anthropic have been suffering, maybe there's some ops acquihire advantage.
For the love of god, don't be true, though.
And Anthropic could build something just as good using its own tool with blackjack and hookers. (In fact, forget the park!(с))
My guess is that Atlassian is getting ready to just ditch Rovo and make a big push to embed Claude maybe?
The only thing I could think of is getting a sales foothold into Fortune 500 companies. "We see you have 1,744 man-years of outstanding bugs, want us to just boil a small lake and replace your dev team?"
There have been rumors all over social media that the exits from Atlassian’s C suite (allegedly firings) and this aggressive privacy violating change are all because their stock is down 80% and they’re trying to find the most valuable path to selling the company.